» Articles » PMID: 35865315

A Novel and Effective Model to Predict Skip Metastasis in Papillary Thyroid Carcinoma Based on a Support Vector Machine

Overview
Specialty Endocrinology
Date 2022 Jul 22
PMID 35865315
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Skip metastasis, referred to as lymph node metastases to the lateral neck compartment without involvement of the central compartment, is generally unpredictable in papillary thyroid carcinoma (PTC). This study aims to establish an effective predictive model for skip metastasis in PTC.

Meterials And Methods: Retrospective analysis was performed of clinical samples from 18192 patients diagnosed with thyroid cancer between 2016 to 2020. The First Affiliated Hospital of Wenzhou Medical University. The lateral lymph node metastasis was occureed in the training set (630 PTC patients) and validation set (189 PTC patients). The univariate and multivariate analyses were performed to detect the predictors of skip metastasis and the support vector machine (SVM) was used to establish a model to predict skip metastasis.

Results: The rate of skip metastasis was 13.3% (84/631). Tumor size (≤10 mm), upper location, Hashimoto's thyroiditis, extrathyroidal extension, absence of BRAFV600E mutation, and less number of central lymph node dissection were considered as independent predictors of skip metastasis in PTC. For the training set, these predictors performed with 91.7% accuracy, 86.4% sensitivity, 92.2% specificity, 45.2% positive predictive value (PPV), and 98.9% negative predictive value (NPV) in the model. Meanwhile, these predictors showed 91.5% accuracy,71.4% sensitivity, 93.1% specificity, 45.5% PPV, and 97.6% NPV in validation set.

Conclusion: This study screened the predictors of the skip lateral lymph node metastasis and to establish an effective and economic predictive model for skip metastasis in PTC. The model can accurately distinguish the skip metastasis in PTC using a simple and affordable method, which may have potential for daily clinical application in the future.

Citing Articles

Predictive factors for lymph node metastasis in papillary thyroid cancer patients undergoing neck dissection: insights from a large cohort study.

Wu S, Liu Y, Ruan X, Zheng X Front Oncol. 2024; 14:1447903.

PMID: 39525620 PMC: 11543528. DOI: 10.3389/fonc.2024.1447903.


Single-center external validation and reconstruction of multiple predictive models for skip lateral lymph node metastasis in papillary thyroid carcinoma.

Li Q, Huang C, Zou H, Zhang J, Xin J Front Endocrinol (Lausanne). 2024; 15:1366679.

PMID: 39319253 PMC: 11420524. DOI: 10.3389/fendo.2024.1366679.


Risk factors and nomogram to predict skip metastasis in papillary thyroid carcinoma.

Zhao Y, Li W, Tao L, Fan J, Zhan W, Zhou W Gland Surg. 2024; 13(2):178-188.

PMID: 38455347 PMC: 10915424. DOI: 10.21037/gs-23-376.


Prospective application of a prediction model for lateral lymph node metastasis in papillary thyroid cancer patients with central lymph node metastasis.

Ma Y, Li Y, Zheng L, He Q Front Endocrinol (Lausanne). 2024; 14:1283409.

PMID: 38239987 PMC: 10795756. DOI: 10.3389/fendo.2023.1283409.


Predicting skip metastasis in lateral lymph nodes of papillary thyroid carcinoma based on clinical and ultrasound features.

Zhao M, Shi X, Zou Z, Wen R, Lu Y, Li J Front Endocrinol (Lausanne). 2023; 14:1151505.

PMID: 37229457 PMC: 10203516. DOI: 10.3389/fendo.2023.1151505.


References
1.
Nixon I, Wang L, Ganly I, Patel S, Morris L, Migliacci J . Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection. Br J Surg. 2015; 103(3):218-25. PMC: 4976488. DOI: 10.1002/bjs.10036. View

2.
Moler E, Chow M, Mian I . Analysis of molecular profile data using generative and discriminative methods. Physiol Genomics. 2000; 4(2):109-126. DOI: 10.1152/physiolgenomics.2000.4.2.109. View

3.
Li X, Li X, Fu X, Liu L, Liu Y, Zhao H . Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients. Eur J Surg Oncol. 2020; 46(10 Pt A):1874-1881. DOI: 10.1016/j.ejso.2019.12.015. View

4.
Zhang C, Zhang L, Xu T, Xue R, Yu L, Zhu Y . Mapping the spreading routes of lymphatic metastases in human colorectal cancer. Nat Commun. 2020; 11(1):1993. PMC: 7181746. DOI: 10.1038/s41467-020-15886-6. View

5.
Machens A, Holzhausen H, Dralle H . Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg. 2004; 139(1):43-5. DOI: 10.1001/archsurg.139.1.43. View